Blog
J.P. Morgan 2024: Insights, Trends, and Tools for Maximizing your Experience
Looking ahead to 2024, professionals worldwide are eagerly gearing up for one of the most anticipated events in the financial calendar—the J.P. Morgan Healthcare Conference. This annual gathering is a…
Read MoreEstablishing a Solid Base of Organic Media Exposure to Secure Top-Tier Coverage
For most companies, attracting top-tier media coverage is a key priority of their strategic communications goals. As a strategic communications and public relations firm collaborating with health and science brands,…
Read MorePros and Cons of AI in Health and Science Public Relations & Investor Relations
Artificial Intelligence (AI) has the potential of changing the PR and IR world as we know it today. In the field of biotech, life sciences, and medical technology where effective communication is crucial for…
Read MoreSupercharge Your Investor Relations and More with Strategic Social Media
Investor relations and social media – two seemingly unrelated entities that, when combined, form a powerful strategy for modern businesses. Much like classic pairings such as peanut butter and jelly, eggs…
Read MoreBalancing Act in Health Communications
Are there differences in managing communications and strategic communications/investor relations (IR) across all industries? Are the basic skills that you would apply to other industries transferable to health and science…
Read MoreCrossing the Data Desert: A How to for Pre-Commercial Biotech IPOs
For pre-commercial life science companies, clinical trial data is king. There may be other members of the court – regulatory decisions, business development and corporate updates – but trial data…
Read More